课题基金 / 基金详情

Improving the efficacy of retinoic-acid-based therapies in triple-negative breast cancer

Improving the efficacy of retinoic-acid-based therapies in triple-negative breast cancer
提高基于视黄酸的疗法对三阴性乳腺癌的疗效
批准号:
317861
负责人:
Coyle Krysta M
金额:
$7.65万
依托单位国家:
加拿大
项目类别:
Studentship Programs
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-10-01 至 2017-10-01

项目摘要

项目成果

Coyle Krysta M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Some patients with breast cancer are diagnosed with triple-negative breast cancer (TNBC). These patients have tumors that have do not express the estrogen and progesterone hormone receptors (ER and PR), or the Her2 protein. Many existing treatments for br
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing RNA regulation in B lymphocytes
Functional characterization of regulatory mutations in mantle cell lymphoma
DNA methylation predicts response of triple-negative breast cancer to all-trans retinoic acid treatment
Characterizing expression and function of the tumor suppressor gene RARRES1 in the differentiation hierarchy of breast cancer
海外基金